AI assistant
STAAR SURGICAL CO — Director's Dealing 2020
Mar 24, 2020
31996_dirs_2020-03-24_6e09771c-5cf5-40a0-b9bb-7065fd642769.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-03-20
Reporting Person: Barnes Scott D (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-20 | Common Stock | A | 9358 | $0.00 | Acquired | 20390 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-20 | Common Stock Options | $27.53 | A | 19457 | Acquired | 2030-03-19 | Common Stock (19457) | Direct |
Footnotes
F1: Award of 9358 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/20/21, 1/3 of the RSUs on 3/20/22, and the remaining 1/3 of the RSUs on 3/20/23.
F2: The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.